Physician profile
Martin Benjamin
NPI 1881960227
$6,404.37
in general payments reported to CMS, 2019-2025
12 companies · $1,792 in 2025
The $1,792 reported for 2025 was more than what 82% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.52 · 2021: $2,416 · 2022: $409 · 2023: $20.11 · 2024: $1,733 · 2025: $1,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,139 · Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,138.69 |
| Food and Beverage | $1,405.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $2,920.61 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Allergan, INC. | $1,584.26 | 2020-2021 | |
| Medical Device Business Services, INC. | $656.58 | 2024 | |
| Sientra, INC. | $636.26 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $274.59 | 2021 | |
| Galderma Laboratories, L.P. | $125.00 | 2025 | |
| Davol INC. | $97.15 | 2022 | |
| Abbvie INC. | $39.97 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $20.11 | 2023 | Seglentis |
| Merz North America, INC. | $19.23 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.23 | 2021 | |
| Integra Lifesciences Corporation | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.